about
Diametrical diseases reflect evolutionary-genetic tradeoffs: Evidence from psychiatry, neurology, rheumatology, oncology and immunologySenescence from G2 arrest, revisitedThree steps to the immortality of cancer cells: senescence, polyploidy and self-renewal.TORC2-a new player in genome stabilityp53 and rapamycin are additive.Quantitative analysis of male germline stem cell differentiation reveals a role for the p53-mTORC1 pathway in spermatogonial maintenance.DNA damage accumulation and TRF2 degradation in atypical Werner syndrome fibroblasts with LMNA mutations.mTOR plays a critical role in p53-induced oxidative kidney cell injury in HIVAN.Cross-talk between HIF and p53 as mediators of molecular responses to physiological and genotoxic stresses.mTOR Inhibition: From Aging to Autism and Beyond.Aging is not programmed: genetic pseudo-program is a shadow of developmental growth.p53 as an intervention target for cancer and aging.Transcriptional regulation of the stress response by mTOR.Exploiting the yeast stress-activated signaling network to inform on stress biology and disease signaling.The role of autophagy in microbial infection and immunity.mTOR inhibitors blunt the p53 response to nucleolar stress by regulating RPL11 and MDM2 levels.Dissecting the transcriptional phenotype of ribosomal protein deficiency: implications for Diamond-Blackfan Anemia.p53 suppresses carcinoma progression by inhibiting mTOR pathway activation.Rapamycin decreases DNA damage accumulation and enhances cell growth of WRN-deficient human fibroblasts.Guaraná, a Highly Caffeinated Food, Presents in vitro Antitumor Activity in Colorectal and Breast Cancer Cell Lines by Inhibiting AKT/mTOR/S6K and MAPKs Pathways.A comprehensive approach to the molecular determinants of lifespan using a Boolean model of geroconversion.mTORC1 Prevents Epithelial Damage During Inflammation and Inhibits Colitis-Associated Colorectal Cancer DevelopmentHuman cellular mitochondrial remodelling is governed by miR-2909 RNomicsBiological Aspects of mTOR in LeukemiaControl of metabolism by p53 - Cancer and beyond
P2860
Q26782139-E467408B-45A3-4F91-A832-E7DE58A21C41Q28088672-51241C31-B3B2-4B33-B03A-1304AA56AC7DQ33590178-274D1307-5633-46A6-AD91-63CBCF201F98Q34131149-7AB8B533-E345-4405-B759-8C6C1C3D8CB8Q36140629-4798B670-12C2-4380-A3A0-6AEB0A6A0839Q36780816-61C244B8-AE29-40C0-8897-E18268AF684BQ36983606-23B56D81-1100-4006-95E4-972D0FAC91ABQ37093673-5D60C641-DE34-4CF3-958D-11FA6EB560BFQ37351778-D61BD9A7-FB2A-4DE1-AE14-576D19E0930EQ37385781-37759244-BB74-4D82-B5D7-CBB0CA0AE245Q37525814-F927F123-5957-49B0-A72E-27E3091F2FA7Q38152454-CC6D486E-EE8B-4E17-9AC4-7194395606E0Q38225367-3E4311A5-7E46-40D8-B082-27F65FE68657Q38468872-68551A61-0FEF-447E-8D64-7D34A1E4CF0BQ38912271-D5E42324-774D-41A0-9262-A96D527A1245Q38931429-7989539C-6D80-45A9-B59E-688265EDD281Q38994386-38474108-3126-44D3-AD59-B9A4BCF568E3Q39029976-1AE6819E-0D25-42FE-94C1-61F8D1AB5F93Q39912029-839CFD11-89EB-4A7D-A200-2B70D5144229Q50966144-75ABF7B3-7CFB-4C4A-BEEC-5301364FF19EQ53770256-B9A204AA-DE10-45FE-AE8B-A3EA0CD4F989Q58698118-583A5F7A-6BF5-4127-9C0E-C6EFBCF24D5CQ58699323-57B72EDF-17C8-4A30-AB64-BA7ED82084F2Q58780065-CD9F80E4-FF3D-44CA-8814-0760C90684EFQ58805589-22E5AA33-5194-4BAF-BE18-83874A2D7B62
P2860
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
mTORC1 and p53: clash of the gods?
@ast
mTORC1 and p53: clash of the gods?
@en
type
label
mTORC1 and p53: clash of the gods?
@ast
mTORC1 and p53: clash of the gods?
@en
prefLabel
mTORC1 and p53: clash of the gods?
@ast
mTORC1 and p53: clash of the gods?
@en
P2093
P2860
P356
P1433
P1476
mTORC1 and p53: clash of the gods?
@en
P2093
Judith Campisi
Paul Hasty
Tyler J Curiel
Zelton Dave Sharp
P2860
P356
10.4161/CC.22912
P577
2013-01-01T00:00:00Z